US Patent Issued to Alpine Immune Sciences on Feb. 17 for "CD86 variant immunomodulatory proteins and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,853, issued on Feb. 17, was assigned to Alpine Immune Sciences Inc. (Seattle).

"CD86 variant immunomodulatory proteins and uses thereof" was invented by Ryan Swanson (Seattle), Dan Ardourel (Seattle), Steven Dennis Levin (Seattle) and Joseph L. Kuijper (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are variant CD86 polypeptides, immunomodulatory proteins comprising variant CD86 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided."

Th...